Reference
Nwogu IB, et al. Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review. Vaccine : 18 Mar 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.02.049
Rights and permissions
About this article
Cite this article
Meningococcal serogroup B vaccination: substantial benefits but not cost effective. PharmacoEcon Outcomes News 875, 17 (2021). https://doi.org/10.1007/s40274-021-7596-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7596-0